Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $8.17 on 7/19/24 after a major decline of -13.8%. Moreover, this decline was accompanied by above average trading volume at 134% of normal. The stock has risen 4.9% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ADVM is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Adverum Biotechnologies has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Adverum Biotechnologies has a neutral Appreciation Score of 49 and a slightly negative Power Rating of 34, resulting in the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment